Dissemin is shutting down on January 1st, 2025

Published in

Elsevier, Digestive and Liver Disease, 4(53), p. 420-426, 2021

DOI: 10.1016/j.dld.2020.11.036

Links

Tools

Export citation

Search in Google Scholar

PRODIGE 59-DURIGAST trial: A randomised phase II study evaluating FOLFIRI + Durvalumab ± Tremelimumab in second-line of patients with advanced gastric cancer

Journal article published in 2021 by Camille Evrard, Christophe Louvet, Farid El Hajbi, Frédéric Di Fiore, Karine Le Malicot, Thomas Aparicio, Olivier Bouché, Pierre Laurent-Puig, Frédéric Bibeau, Thierry Lecomte, Astrid Lièvre, Rosine Guimbaud, Stefano Kim, Aziz Zaanan, Harry Sokol and other authors.
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Upload
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO